Hypomanic episode following COVID - 19 Pneumonia - case report

Kuruthikadavath Kurussithodi Hridya; Surendran Kalambattumadathil Surabhi; Pankajakshan Vijayanthi Indu

doi:10.30834/KJP.35.1.2022.281

Authors

Kuruthikadavath Kurussithodi Hridya Junior Resident, Department of Psychiatry,Government Medical College, Kozhikode
Surendran Kalambattumadathil Surabhi Junior Resident, Department of Psychiatry, Government Medical College, Kozhikode
Pankajakshan Vijayanthi Indu Additional Professor, Department of Psychiatry, Government Medical College, Kozhikode

DOI:

https://doi.org/10.30834/KJP.35.1.2022.281

Keywords:

hypomania, COVID-19, pneumonia

Abstract

Coronavirus disease-2019 (COVID-19), an acute respiratory infection caused by severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), was declared a pandemic in early 2020. Although the virus primarily affects respiratory and gastrointestinal systems, it is neurotropic and has neuropsychiatric complications. The most common neuropsychiatric manifestations seen in COVID-19 infection include delirium, depression, anxiety and post-traumatic stress disorder; very few cases of mania have been reported. Here, we report two cases –an elderly male and a middle-aged female – without a past history of psychiatric illness, presenting with hypomanic episodes following COVID-19 infection. Their blood investigations were normal, and neuroimaging revealed chronic and age-related changes only. As they showed a good response to mood stabilizer, further evaluation including the CSF study was deferred. Psychiatric symptoms could have been the outcome of an interaction of the psychosocial stressors associated with the pandemic on the brain, which was made vulnerable by the COVID-19 infection.

References

Karia R, Gupta I, Khandait H, Yadav A, Yadav A. COVID-19 and its mode of transmission. SN Compr Clin Med 2020. doi:10.1007/s42399-020-00498-4.

Mirfazeli FS, Sarabi-Jamab A, Jahanbakhsi A, Kordi A, Javadnia P, Shariat SV, et al. Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptoms. Scientific Reports 2020;10:20957. doi:1038/s41598-020-78050-6.

Nakamura ZM, Nash RP, Laughon SL, Rosenstein DL. Neuropsychiatric complications of COVID-19. Current Psychiatry Reports 2021;23;25. doi:10.1007/s11920-021-01237-9.

Lu S, Wei N, Jiang J, Wu L, Sheng J, Zhou J, et al. First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder. Journal of Affective Disorders 2020;277:337-340. doi:10.1016/j.jad.2020.08.031.

Mawhinney JA, Wilcock C, Haboubi C, Haboubi H, Roshanzamir S. Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode. BMJ Case Rep 2020;13:e236123. doi:10.1136/bcr-2020-236123.

Butler M, Pollak TA, Rooney AG, Michael BD, Nicholson TR. Neuropsychiatric complications of covid-19: From acute delirium to long-term fatigue, covid-19 has serious neuropsychiatric effects. BMJ 2020;371:m3871. doi:10.1136/bmj.m3871.

Banerjee D, Viswanath B. Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insight from other coronaviruses. Asian J Psychiatry 2020;54:102350. doi:10.1016/j.ajp.2020.102350.

Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020;7:611-627. doi:10.1016/S2215-0366(20)30203-0.

Kaggwa MM, Bongomin F, Najjukka SM, Rukundo GZ, Ashaba S. Cannabis-induced mania following COVID-19 self-medication: A wake-up call to improve community awareness. International Medical Case Reports Journal 2021;14:121–125. doi:10.2147/IMCRJ.S301246.

Marchini S, Ormelingen OV, Delhaye M. First manic episode in 14-year-old adolescent during COVID-19 lockdown measures: A case report. Annals of Psychiatry and Treatment 2020;4(1):034-036. doi:10.17352/apt.000018.